Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Ann N Y Acad Sci ; 943: 326-39, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11594552

ABSTRACT

Our objective was to assess the perinatal management and neonatal outcomes of premature, severely intrauterine growth-restricted (IUGR) neonates. A cohort of neonates <1000 grams, < or = first percentile for weight, and <37 weeks' gestation was identified and matched 2:1 to two control sets of premature, appropriate-for-gestational age (AGA) infants-one with similar gestational age (AGA-GA group) and the other with similar birth weight (AGA-BW group) to determine the effect of IUGR on the outcome of the premature infant. The IUGR group was then examined in detail for descriptive statistics. Data were analyzed by t-tests and Chi-square analyses where appropriate. The IUGR infants had worse outcomes than AGA-GA controls but had somewhat better results than the AGA-BW controls. In the IUGR group, a birth weight less than 550 grams was significantly associated with neonatal death (p < 0.001). However, increasing gestational age was not associated with neonatal survival (p = 0.661) if birthweight remained below 550 grams. Classical cesarean delivery was associated with neonatal death (p = 0.003). Neonatal variables associated with poor outcome included patent ductus arteriosus (p = 0.034), feeding intolerance (p = 0.046), and failure to thrive (p = 0.05). Overall, neonatal survival was 73%. Of the surviving neonates, 69% had evidence of neurodevelopmental delay when tested at 6 and 12 months. Premature, growth-restricted neonates with birth weights of <550 grams versus those of >550 grams have dismal outcomes despite a gestational age that is compatible with survival.


Subject(s)
Birth Weight/physiology , Fetal Growth Retardation/mortality , Adult , Cohort Studies , Delivery, Obstetric , Female , Gestational Age , Humans , Infant, Newborn , Postnatal Care , Pregnancy , Pregnancy Outcome , Risk Factors , Survival Analysis
2.
Pediatrics ; 103(4 Pt 1): 759-65, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10103299

ABSTRACT

OBJECTIVE: To determine, in the postsurfactant era, the incidence and clinical characteristics of infants with atypical versus traditionally defined bronchopulmonary dysplasia (BPD) among premature infants with birth weights <1251 g. DESIGN: Retrospective cohort study. SETTING: A single regional neonatal intensive care unit (level III/IV). PATIENTS: Two hundred thirty-two premature infants <1251 g at birth consecutively admitted during a 2-year period. MAIN OUTCOME MEASURE: Incidence of classic BPD and atypical chronic lung disease (CLD) (occurring without preceding respiratory distress or after recovery from respiratory distress). RESULTS: Among 177 infants <1251 g who survived to 28 days, 27 (15%) had atypical CLD and 61 (34.5%) had classic BPD. Atypical CLD infants were significantly heavier and more mature than classic BPD infants (mean birth weights, 922 +/- 152 g vs 854 +/- 173 g; and mean gestational age, 26.8 +/- 1.3 weeks vs 26.1 +/- 1.6 weeks). Median duration of ventilator support (31 days; range, 2 to 127 vs 42 days; range, 4-145 days) and oxygen therapy (30 days; range, 11 to 163 vs 48 days; range, 19-180 days) were shorter in atypical CLD infants than in classic BPD infants. CONCLUSION: Atypical CLD comprised 31% of total cases of CLD. Atypical CLD appears to be less severe than classic BPD. These data suggest that initial, acute lung injuries are not the sole antecedents of neonatal CLD.


Subject(s)
Infant, Premature, Diseases/epidemiology , Infant, Very Low Birth Weight , Lung Diseases/epidemiology , Bronchopulmonary Dysplasia/epidemiology , Bronchopulmonary Dysplasia/therapy , Chronic Disease , Cohort Studies , Female , Humans , Incidence , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/therapy , Intensive Care Units, Neonatal , Lung Diseases/therapy , Male , Regression Analysis , Retrospective Studies
3.
Am J Physiol ; 276(1): L105-13, 1999 01.
Article in English | MEDLINE | ID: mdl-9887062

ABSTRACT

Acute hyperoxic lung injury remains a major factor in the development of chronic lung disease in neonates. A critical step in the repair of acute lung injury is the proliferation of type II alveolar epithelial cells. Type II cell proliferation is stimulated by keratinocyte growth factor (KGF), an epithelial cell-specific mitogen. We sought to investigate KGF mRNA expression in relation to type II cell proliferation during hyperoxic lung injury. We studied a previously described newborn (NB) rabbit model of acute and chronic hyperoxic injury [C. T. D'Angio, J. N. Finkelstein, M. B. LoMonaco, A. Paxhia, S. A. Wright, R. B. Baggs, R. H. Notter, and R. M. Ryan. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L720-L730, 1997]. NB rabbits were placed in 100% O2 for 9 days and then recovered in 60% O2. RT-PCR was used to synthesize and amplify a 267-bp fragment of rabbit KGF cDNA from whole lung RNA. KGF mRNA expression was analyzed by ribonuclease protection assay, and mRNA abundance was quantified by phosphorimaging. Proliferating cell nuclear antigen immunohistochemistry was used on lung sections to identify proliferating cells. The rabbit partial cDNA sequenced was >95% homologous to human cDNA, and all amino acids were conserved. Whole lung KGF mRNA expression was increased 12-fold after 6 days of hyperoxia compared with control lungs, and remained increased throughout the 100% O2 exposure period. Proliferating cell nuclear antigen immunohistochemistry showed an increase in type II cell proliferation after 8-12 days of hyperoxia. NB rabbits exposed to hyperoxic injury exhibit increased whole lung KGF mRNA expression preceding type II cell proliferation. KGF may be an important mitogen in the regulation of alveolar epithelial repair after hyperoxic lung injury.


Subject(s)
Animals, Newborn/metabolism , Fibroblast Growth Factors , Growth Substances/genetics , Hyperoxia/metabolism , Lung/metabolism , RNA, Messenger/metabolism , Amino Acid Sequence/genetics , Animals , Base Sequence/genetics , Cell Division/physiology , DNA, Complementary/genetics , Epithelial Cells/pathology , Fibroblast Growth Factor 10 , Fibroblast Growth Factor 7 , Humans , Hyperoxia/pathology , Hyperoxia/physiopathology , Lung/physiopathology , Molecular Sequence Data , Proliferating Cell Nuclear Antigen/metabolism , Pulmonary Alveoli/pathology , Rabbits , Wound Healing/physiology
4.
J Perinatol ; 19(1): 61-3, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10685204

ABSTRACT

We describe in this report the development of disseminated intravascular coagulopathy in a neonate after transtorcular embolization of an unusual vein of Galen aneurysm. This rare but potentially fatal complication associated with transtorcular embolization should be considered in decision-making and prognostic evaluation processes, especially in neonates with severe heart failure.


Subject(s)
Cerebral Veins , Disseminated Intravascular Coagulation/etiology , Embolization, Therapeutic , Intracranial Aneurysm/complications , Intracranial Aneurysm/therapy , Cerebral Angiography , Fatal Outcome , Humans , Infant, Newborn , Intracranial Aneurysm/diagnostic imaging , Intracranial Arteriovenous Malformations/complications , Intracranial Arteriovenous Malformations/diagnostic imaging , Male , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...